Catalent To Showcase Innovative Omega-3 Dose Forms And Lead Informative Sessions At SupplySide West
SOMERSET, N.J. – September 18, 2017 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to participate in a half-day workshop, along with Euromonitor International, on the formulation of consumer health products, as part of SupplySide West, which runs from Sept. 25 – 29, 2017, at the Mandalay Bay Hotel and Resort, Las Vegas.
Titled “Supporting Healthy Aging with Targeted Formulations, Product Forms,” the workshop will take place Tuesday, Sept. 26, at 1:30 p.m. Key industry leaders contributing to the discussion will include Dr. Jeffrey E. Browne, Catalent’s Director of Science and Technology. The workshop will provide industry scientists and executives with information on aging trends, innovative formulation technologies and emerging solutions targeted to meet the specific needs of the aging consumer.
Dr. Browne will also contribute to a Global Organization for EPA and DHA Omega-3 (GOED)-moderated panel discussion on the problems of product oxidation in the industry on Wednesday, Sept. 27 at 11.45 a.m. at the Omega-3 Resource Center Theater.
Catalent is the exclusive sponsor of the GOED Pavilion at the show, and will be showcasing its new high potency Omega–3 product, EasyBurst® chewable fish oil, throughout the event at booth N147. This innovative chewable product addresses several of the challenges associated with fish oil supplements, including large capsule size, odors and unpleasant aftertaste, offering consumers a smaller, chewable dosage form that does not require water.
Additionally, on Wednesday, Sept. 27 at 3:30 p.m., Timothy Doran, Vice President and General Manager of Nutritional Softgels, will present “Omega-3 Innovative Dosage Forms” at the GOED Pavilion, where he will discuss unique Omega-3 formulation considerations and innovative dosage forms.
For more information visit Catalent booth LL159. To arrange a meeting with any of the attending Catalent executives at the event, contact Richard Kerns at NEPR richard@nepr.eu.
Media Contacts:
Chris Halling
+44 (0)7580 041073
chris.halling@catalent.com
Richard Kerns
+44 (0) 161 728 5880
richard@nepr.eu
ABOUT CATALENT
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated more than $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com